Kathy Giusti to Address HBS Graduating Class

The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.

Kathy Giusti

Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.  

Sub topics

You might also like

Veteran MIT Administrator Named University Secretary

Suzanne Glassburn will manage the work of the Corporation and Board of Overseers.

The 2025 Pulitzer Prizes Announced

Winners across five categories, from commentary on Gaza to criticism on public architecture

Harvard Medalists

Four people honored for exceptional service to the University

Most popular

Danielle Allen Debates Far-Right Blogger Curtis Yarvin

Popular monarchist debates Allen on democracy.

FAS Dean Outlines Preparations for Loss of Federal Funding

“To preserve our mission, we must act now,” Hoekstra says at faculty meeting

The New Gender Gaps

What to do as men and boys fall behind

Explore More From Current Issue

The Franklin Stove—A Historical Climate Change Adaptation

Historian Joyce E. Chaplin reinterprets an early era of invention, industrialization, and climate challenge

The Sum of Our Choices

On the limitations of a prevailing worldview

Publications by Harvard Authors Spring 2025: New Releases

Operatic counterculture, a Passover graphic novel, James Joyce’s biographer, and more